SEC Form 4 · accession 0001225208-16-033578
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas J Valeriani
Director
Period of report
May 13, 2016
Accepted (ET)
May 17, 2016 · 8:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | May 13, 2016 | A | 1,941 | $0.00 | A | 4,983 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These restricted stock units were granted on May 13, 2016 under Issuer's Nonemployee Directors Stock Incentive Program. They are scheduled to become vested 100% on May 11, 2017, and the underlying common stock (net of any shares sold to cover applicable taxes) must be held until the director ceases to serve on the Board.
- F2On December 11, 2015, Issuer's common stock split 2-for-1, resulting in the reporting persons' ownership of additional shares of common stock and stock options. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.